Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-10-26

Clinical Trial Update: Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation [NA]

View source ↗

Summary

Clinical trial update on prophylactic piperacillin/tazobactam for neutropenia in hematopoietic stem cell transplantation patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Neutropenia, Hematopoietic Stem Cell Transplantation | NA | Status: UNKNOWN